Mohamed Rafiq

Mohamed Rafiq


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
VGVani Gangwar
Vani Gangwar
AGAmar Garg
Amar Garg
KLKaran Lomore
Karan Lomore
KKKalyani Korla
Kalyani Korla
SBShruthi Bhat
Shruthi Bhat
KVKV Venkatesh
KV Venkatesh
Natural bioactive compounds derived from plant-based products are known for their biological immunomodulatory activities. They possess systemic pleiotropic effects, minimal side effects, and very low toxicities. Plant-based bioactive compounds have tremendous potential as natural therapeutic entities against various disease conditions and act as anti-inflammatory, antioxidant, anti-mutagenic, anti-microbial, anti-viral, anti-tumour, anti-allergic, neuroprotective, and cardioprotective agents. A herbal formulation extract including five biologically active compounds: Apigenin, Quercetin, Betulinic acid, Oleanolic acid, and β-Sitosterol can impart several immunomodulatory effects. In this review, we systematically present the impact of these compounds on important molecular signaling pathways, including inflammation, immunity, redox metabolism, neuroinflammation, neutropenia, cell growth, apoptosis, and cell cycle. The review corroborates the beneficial effect of these compounds and shows considerable potential to be used as a safer, more cost-effective treatment for several diseases by affecting the major nodal points of various stimulatory pathways.

11 March 2014 in ISRN Pharmacology
Verified
Journal Article
Open access
PDF file
MAMohammed Azeemuddin
Mohammed Azeemuddin
GVGollapalle L Viswanatha
Gollapalle L Viswanatha
MRMohamed Rafiq
Mohamed Rafiq
ATAgadi HireMath Thippeswamy
Agadi HireMath Thippeswamy
MBMirza Rizwan Baig
Mirza Rizwan Baig
RSRamakrishnan Shyam
Ramakrishnan Shyam
Objective. To improve the existing experimental model of croton oil-induced hemorrhoids in rats by using Evans Blue (EB) dye extravasation technique. Further, an herbal formulation (Pilex) was evaluated for its antihemorrhoidal activity in this model. Methods. Two sets of experiments were carried out: first to improve the experimental model and to validate the same using Pilex and second to evaluate the effect of Pilex on cytoarchitecture of rectoanal tissue in croton oil-induced hemorrhoids. In both sets, hemorrhoids were induced to all the animals, except normal controls, by applying croton oil via rectoanal region and the effect of Pilex ointment (PO), Pilex granules (PG), and combination of PG and PO was evaluated. In the first set, extravasation of EB dye, TNF-α, IL-6, and rectoanal coefficient (RAC) was determined. In the second set, severity of score, RAC, and histopathology were evaluated. Results. The elevated levels of TNF-α, IL-6, and extravasations of EB dye were decreased with the Pilex treatment. The cytoarchitecture of rectoanal portion of the animals treated with Pilex was near to normal. Conclusion. The improved experimental model of hemorrhoid is useful in quantifying the inflammatory exudates and extent of inflammation. In this improved experimental model Pilex showed antihemorrhoidal activity, which further validates its clinical usage.

18 October 2022 in Cosmetics
Verified
Journal Article
Open access
PDF file
PSPrachi Singh
Prachi Singh
SBShruthi Bhat
Shruthi Bhat
NSNikhil Singh
Nikhil Singh
BVBabu U. Venkanna
Babu U. Venkanna
MRMohamed Rafiq
Mohamed Rafiq
RRRaghavendra Pralhada Rao
Raghavendra Pralhada Rao
Cosmetic formulations have evolved significantly over the years. These are no longer viewed merely as beauty-enhancing products. Rather, they are expected to deliver additional benefits to the skin that positively affect the skin health. There is a renewed interest in using herbal extracts and herbal ingredients in cosmetic products since they offer several advantages over synthetic ingredients. Evaluating the cosmetic ingredients for their efficacy and safety is critical during product development. Several regulatory bodies impose restrictions on using animals for testing these ingredients in cosmetic products. This has increased the need for developing novel cell-based or cell-free biological assays. The current article systematically presents in-vitro/cell-based and/or cell-free strategies for validating the efficacies of cosmetic ingredients for skin health and hair growth. The article focuses on details about various assays for the anti-acne effects, hair-growth-promoting activities, anti-aging activities, skin-rejuvenating properties, wound-healing effects, and skin-depigmentation activities of natural ingredients in cosmetic formulations.

1 April 2016 in Journal of Traditional and Complementary Medicine
Verified
Journal Article
Open access
MAMohammed Azeemuddin
Mohammed Azeemuddin
MRMohamed Rafiq
Mohamed Rafiq
SASuryakanth Dattatraya Anturlikar
Suryakanth Dattatraya Anturlikar
LKLakkavalli Mohan Sharath Kumar
Lakkavalli Mohan Sharath Kumar
PPPralhad Sadashiv Patki
Pralhad Sadashiv Patki
RSRamakrishnan Shyam
Ramakrishnan Shyam
The objective of the present study is to evaluate the effect of the extract of a well-known hepatospecific polyherbal formulation, Liv.52, in an experimental model of high-fat diet (HFD)-induced nonalcoholic steatohepatitis (NASH) in rats. Feeding a HFD for 15 weeks resulted in significant impairment of the lipid profile, elevation of hepatic enzyme markers, and insulin resistance in rats. The histological examination of the liver furthermore indicated fibrotic changes and fat deposition in hepatic tissues. The treatment with Liv.52 extract [125 mg/kg body weight per os (b.wt. p.o.)], which was administered from week 9 onward, reversed the HFD-induced changes to a statistically significant extent, compared to the untreated positive control animals. The effect observed with Liv.52 extract was comparable to that of pioglitazone (4 mg/kg b.wt.), a standard drug that is useful in the management of NASH. The treatment with Liv.52 extract significantly reduced steatosis, collagen deposition, and necrosis in hepatic tissues, which indicates its antifibrotic and antinecrotic properties. The results obtained in the present set of experiments indicate that Liv.52 extract effectively reverses metabolic and histological changes associated with HFD-induced NASH.

1 March 2014 in Journal of Pharmacological and Toxicological Methods
Verified
Journal Article
Closed access
GVGollapalle L Viswanatha
Gollapalle L Viswanatha
ATA.H.M. Thippeswamy
A.H.M. Thippeswamy
MRMohamed Rafiq
Mohamed Rafiq
MJM. Jagadeesh
M. Jagadeesh
MBMirza Rizwan Baig
Mirza Rizwan Baig
SRShyam Ramakrishnan
Shyam Ramakrishnan

3 February 2019 in Advances in Pharmacological Sciences
Verified
Journal Article
Open access
PDF file
MAMohammed Azeemuddin
Mohammed Azeemuddin
SASuryakanth D. Anturlikar
Suryakanth D. Anturlikar
MOMallappa Onkaramurthy
Mallappa Onkaramurthy
MBMirza R. Baig
Mirza R. Baig
BABasti K. Ashok
Basti K. Ashok
PRParamesh Rangesh
Paramesh Rangesh
The objective of the present study was to evaluate “DXB-2030,” a polyherbal combination of Trigonella foenum-graecum, Aloe vera, Sphaeranthus indicus, Nardostachys jatamansi, and Symplocos racemosa extracts in an experimental model of testosterone propionate (TP), induced polycystic ovary syndrome (PCOS) in female rats. Thirty animals were divided into 3 groups of 10 each; group 1 served as normal control; group 2 was administered with TP and served as positive control; along with TP, group 3 was treated with “DXB-2030” at a dose of 100 mg/kg p.o., for 60 days. At the end of the study period, the animals were subjected for the estimation of serum testosterone levels, oral glucose tolerance test (OGTT), weight of the ovaries, estrous cycle, and histopathological evaluation. An in vitro assay on GLUT4 expression was carried out to understand the effect of “DXB-2030” on insulin resistance. Results showed that treatment with “DXB-2030” reversed the TP-induced changes by increasing the GLUT4 expression and decreasing the body weight, testosterone levels, AUC of glucose in OGTT, and the cystic follicles of the ovaries, thus indicating its beneficial effect in PCOS by ameliorating the metabolic dysfunction and reproductive impairment, which are the pathophysiological conditions associated with PCOS. From the results obtained, it can be concluded that “DXB-2030” was effective in the management of experimental PCOS and hence may be recommended in the treatment of PCOS.